Global Community

MindWalk is no longer just a lab-for-hire biotech company; it is building a software platform that helps drug teams predict what molecules will do, and the market may not be keeping up with that shift. The upside hinges on whether big customers adopt its LensAI platform and whether its vaccine and metabolic drug candidates prove out without forcing shareholders to fund endless experiments.Read more

Macnica’s chip-trading business keeps growing thanks to strong demand linked to AI and overseas customers, but its push into autonomous driving is taking longer to turn pilots into real deployments. See what this mix of steady core demand and a delayed new growth engine could mean for profits and the company’s outlook.Read more

Microsoft is no longer just the company behind Windows and Office—it’s becoming a behind-the-scenes provider that many businesses rely on to run and manage new AI tools, no matter which AI maker comes out on top. The big question is whether its heavy spending to build out this capability turns into years of stronger growth, or becomes an expensive gamble if demand cools.Read more

Robo.ai puts a former international police chief in charge of a new Abu Dhabi-based unit aimed at building secure AI systems for governments and critical infrastructure. The move signals a push into high-stakes public-sector work where trust, safety, and compliance can make or break growth.Read more

Right Now META is sitting at $544.20. Wednesday's close was $585.61.Read more

Pagaya Technologies is entering a "Goldilocks" scenario. For the last two years, it operated under high interest rates, which compressed margins.Read more

After a sharp sell-off, PROCEPT BioRobotics may be getting punished more for shifting how it reports sales than for any real slowdown in what doctors are doing. The bigger question is whether a feared medical procedure trend is actually a non-issue, and if upcoming results can reset sentiment.Read more

Hims & Hers grows from a telehealth brand into a broader online healthcare service that spans everything from primary care to mental health and weight management. The big question is whether it can keep growing while handling changing rules around popular weight-loss treatments and rising competition from much larger players.Read more

Charter is finishing a costly network upgrade, and the business could soon throw off a lot more cash that it can use to shrink debt and buy back shares. Even with slow customer growth, the author argues the market is overlooking hidden value in the company’s debt and the potential upside from a deal or partnership buzz.Read more